New data suggests the risk of blood clots from Astra-Zeneca is 1 in 60,000.
Ontario is going to pause first doses of the Oxford Astra-Zeneca vaccine over concerns around blood clots.
Chief Medical Officer of Health Dr. David Williams made the announcement during a press briefing this afternoon. New data suggests the risk of blood clots from Astra-Zeneca is higher then previously thought at 1 in 60,000.
This is not expected to impact the vaccine rollout in Ontario thanks to increased supply from Pfizer and Moderna.
The Province is currently reviewing data for second doses and it is possible those who got the first shot of Astra-Zeneca could end up with a second dose from Pfizer or Moderna. According to recent data, the risk of blood clots from the second dose of Astra-Zeneca is much smaller.
Dr. Williams did say anyone who already received the first dose of Astra-Zeneca did the right thing and this decision was made out of an abundance of caution. He notes the increased supply of Moderna and Pfizer helped make this an easier decision.

Oxford County Releases Survey Results
Cheese and Cheers Coming to Woodstock
PJHL Preview - Oct 30th to Nov 1st
Navy Vets Preview - Nov 1st
Daylight Saving Time Ends Sunday
Halloween Safety Tips from WPS
Patrick Stewart Dead at 86
SWOX Crash Results in Minor Injuries
UPDATE: Deceased Identified in Homicide Investigation
Interview with the Warden - October 29th, 2026
News Poll: Oxford County Municipal Election Results
Milwaukee Brewers Win the World Series
Great Pumpkin Rescue Returns for 2026
Oxford County Continues Watermain Flushing
Poppy Campaign Underway in Oxford
Norfolk OPP Briefs - October 28th, 2026
Increased Voter Turnout in Woodstock
Tip Tuesday with the Oxford OPP - October 2026
Acchione Re-elected as Woodstock Mayor
Comments
Add a comment